Navigation Links
Testosterone Replacement Therapy Safe If Monitored Appropriately

About 2 million to 4 million men in the United States have low levels of testosterone. Symptoms of the condition // may include erectile dysfunction, reduced muscle mass, reduced bone density, depression, and anemia.

Testosterone replacement therapy is designed to increase testosterone levels for men with the condition. The therapy may be offered as an injection, patch, gel, or tablet. New research shows testosterone replacement therapy does not increase a man’s risk of developing prostate cancer or heart disease. However the side effects of testosterone replacement therapy include acne, sleep apnea, fluid retention, and infertility.

Researchers reviewed more than 70 studies that examined the safety of testosterone replacement therapy. Results show the therapy was not associated with an increased risk of prostate cancer or cardiovascular disease. Previous studies have shown extremely low levels of testosterone can shrink prostate cancer that has spread. That’s why some have raised concern over increasing testosterone levels in men who are deficient. However, researchers of the current study point out that prostate cancer becomes more prevalent when testosterone levels decline. They found no connection between high testosterone levels and prostate cancer.

Researchers say some people believe testosterone is a risk factor for cardiovascular disease because men, who have higher levels of the hormone, are more likely to have a cardiac event than women. However, researchers say there is little evidence to support this assumption.

Thus researchers conclude: “Testosterone is only for men who have symptoms of low testosterone combined with a confirmatory blood test. Testosterone therapy can be beneficial and safe for these men as long as they are appropriately monitored by their physician.”
'"/>




Page: 1

Related medicine news :

1. Low Testosterone Levels the Cause Of Depression In Men
2. The Use Of Testosterone Replacement Therapy Questioned
3. Depression In Men Could Be To Low Testosterone Levels
4. Testosterone patch for women Rejected For safety Reasons
5. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
6. Testosterone Therapy can improve sexual function in postmenopausal women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... ... 2017 , ... Dr. Kiya Green, a periodontist in Matthews, ... treatments, including crown lengthening and gum reduction surgery, with or without ... procedures to help patients improve their oral health, reduce gummy smiles and achieve ...
(Date:5/22/2017)... ST. PAUL, Minn. (PRWEB) , ... May 22, 2017 , ... ... one young man’s experience learning to live with Bipolar 1. Donald Rodriguez takes readers ... icy mountain in Alaska in the dead of winter and to a dark place ...
(Date:5/22/2017)... Francisco, CA (PRWEB) , ... May 22, 2017 ... ... will sponsor a program on Wellocity to empower WeightZone Factor members to ... their medications, and get an excellent health education, all on their mobile phones. ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest ... James (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart ... innovation and business performance. He defines strategic roadmaps by reimagining business processes—bridging the ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... Pot. Reefer. ... find it, review it, and share its attributes like never before. More than a ... to connect cannabis enthusiasts to stores, strains, products – and for the first time ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... May 10, 2017  The Corporate Whistleblower Center ... of sleep therapy clinics to call us anytime ... clinic is involved in a substantial scheme to ... hearing from an employee of a medical equipment ... scheme to provide medical practice groups with extra ...
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
Breaking Medicine Technology: